Deng, PhD, Xiaobing, et al. “Screening Genetic Alterations of Biomarkers BRAF, ROS-1, and HER2 by Immunohistochemistry in Ovarian Carcinomas for Targeted Therapy”. North American Journal of Medicine and Science, vol. 10, no. 2, Apr. 2017, https://najms.com/index.php/najms/article/view/334.